Abbott Diabetes Care Medical Device Inserter Patent Granted

The USPTO has issued patent US12605186B2 to Abbott Diabetes Care Inc., granting exclusive intellectual property rights to an apparatus for inserting medical devices into the skin of a subject and associated methods. The patent contains 19 claims covering the inserter device and its uses.

Medical device manufacturers and competitors in the diabetes care or continuous glucose monitoring space should be aware that practicing the claimed invention—specifically any apparatus for medical device insertion using the claimed mechanisms—without Abbott's authorization may constitute patent infringement. Parties developing similar insertion technologies should review the CPC classifications (A61B 5/1411, A61B 5/14503, A61M 5/158, among others) to assess potential design-around opportunities.